-
Racial Disparity Seen in Prescriptions for Buprenorphine
drugs
May 21, 2019
Racial Disparity Seen in Prescriptions for Buprenorphine.
-
Recs Updated for TB Screening, Treatment in Health Care Workers
drugs
May 17, 2019
Recs Updated for TB Screening, Treatment in Health Care Workers.
-
NHS improvements to give patients faster access to pioneering treatments
pharmatimes
May 09, 2019
NHS improvements to give patients faster access to pioneering treatments.
-
New Treatment Guideline Focuses on Tourette Syndrome
drugs
May 09, 2019
New Treatment Guideline Focuses on Tourette Syndrome.
-
EU approval for Sanofi’s type 2 diabetes treatment
europeanpharmaceuticalreview
May 08, 2019
Suliqua is an innovative new combination therapy that has the potential to address significant unmet needs for people living with type 2 diabetes in Europe
-
World Asthma Day: can fevipiprant revolutionise asthma treatment?
pharmaceutical-technology
May 07, 2019
World Asthma Day aims to raise awareness of the burden of asthma. Increasingly, the standard of care for asthma, reliever and preventer inhalers, are being discovered to be insufficient in a number of ways.
-
Anti-malaria drug shows promise as Zika virus treatment
europeanpharmaceuticalreview
May 05, 2019
Chloroquine found to reduced the amount of Zika virus in maternal blood and neural progenitor cells in the foetal brain.
-
Cabozantinib shows promise as first line treatment for differentiated thyroid cancer
europeanpharmaceuticalreview
May 05, 2019
A kinase inhibitor called cabozantinib could be a viable therapy option for patients with metastatic, radioactive iodine-resistant thyroid cancer…
-
Long-lasting opioid treatment recommended by an EMA committee
europeanpharmaceuticalreview
May 05, 2019
Marketing authorisation has been recommended in the EU by an EMA committee for Sixmo (buprenorphine) as a substitution treatment for opioid dependence.
-
Cardiff Met develops new cancer treatment
europeanpharmaceuticalreview
April 30, 2019
Cardiff Metropolitan University has been instrumental in the development of a new anti-cancer agent that has the potential to offer a valuable treatment option for cancer…